abstract |
A compound of formula (I) wherein X, R1, R2a, R3a, R3b, R4a, R4b, R4c and R5 are defined herein. The present invention provides tetrahydroisoquinoline compounds, useful as modulators of nuclear receptors, including liver X receptor (LXR) and/or orphan nuclear receptor activity, and to pharmaceutical composition containing such compounds. |